Bank stocks led European equities traded in the US as American depositary receipts higher late Tuesday morning, rising 0.80% to 1,418.65 on the S&P Europe Select ADR Index.
From continental Europe, the gainers were led by telecommunications company Ericsson (ERIC) and biopharmaceutical company Grifols (GRFS), which rose 3.3% and 2.7% respectively. They were followed by financial services companies Banco Santander (SAN) and Banco Bilbao Vizcaya Argentaria (BBVA), which increased 2.6% and 2.2% respectively.
The decliners from continental Europe were led by biotech firm Evaxion Biotech (EVAX) and 3D printer company Materialise (MTLS), which shed 10% and 8% respectively. They were followed by internet browser company Opera (OPRA) and biopharmaceutical company DBV Technologies (DBVT), which dropped 4.3% and 1.2% respectively.
From the UK and Ireland, the gainers were led by medical device maker Smith & Nephew (SNN) and financial services company HSBC (HSBC), which were up 6.1% and 2.6% respectively. They were followed by pharmaceutical company GSK (GSK) and financial services company Lloyds Banking Group (LYG), which advanced 2.6% and 1.5% respectively.
The decliners from the UK and Ireland were led by biopharmaceutical companies NuCana (NCNA) and TC Biopharm (TCBP), which fell 7% and 5.3% respectively. They were followed by biopharmaceutical companies Akari Therapeutics (AKTX) and Biodexa Pharmaceuticals (BDRX), which were down 7.8% and 3%, respectively.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。